Benefits
-
Reduces appetite and food cravings increases the feeling of fullness
-
Lowers weight waist size blood pressure blood sugar and inflammation
-
The majority of patients had at least 15% weight loss with many losing more than 20%
-
Weekly painless under-the-skin injections activating GLP-1
-
Regular consultations with a medical provider
-
Newly FDA-approved for weight loss safely used for diabetes since 2017
SEMAGLUTIDE
Semaglutide, a newly approved medication by the U.S. Food and Drug Administration (FDA), aids in weight loss. Marketed as Ozempic, Rybelsus, and Wegovy, it is prescribed alongside a low-calorie diet and exercise regimen to assist individuals in shedding pounds.
Categorized as an incretin mimetic, semaglutide prompts the pancreas to release insulin during periods of elevated blood sugar levels. Another variant of semaglutide, available as Ozempic, is utilized for managing blood sugar levels among individuals diagnosed with type 2 diabetes.
